Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
DOI: 10.3390/vaccines7010033
Adrian V. S. Hill,
Alison Lawrie,
Amy Flaxman,
Angela Minassian,
Catherine Mair,
Celia Mitton,
Chris Ellis,
Duncan Bellamy,
Fernando Ramos Lopez,
Ian Poulton,
Katie J. Ewer,
Megan Baker,
Pedro M. Folegatti,
Rachel Roberts,
Raquel L. Ramon,
Sarah C. Gilbert,
Thomas G. Evans
Keywords: influenza, heterosubtypic vaccine, safety, immunogenicity, viral vectors
Abstract:
Full-Text
